
Justin Schweitzer, OD, FAAO, discusses his talk, "Current trends in keratoconus management," at Vision Expo West 2023 in Las Vegas, Nevada.

Justin Schweitzer, OD, FAAO, discusses his talk, "Current trends in keratoconus management," at Vision Expo West 2023 in Las Vegas, Nevada.

The course reviews fitting various contact lenses, looks at practice management essentials, and discusses treatment of contact lens complications.

Easy-to-use modality offers exciting benefits for patients.

Lyndon Jones, PhD, DSc, FCOptom, FAAO, showcases topics discussed in the Global Contact Lens Forum at Vision Expo West 2023.

OGS has begun its funding season as the organization looks ahead to wrapping up 2023 and kicking off 2024.

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.

The theme calls on employers, insurers, and policy makers to consider how they can contribute to improved access to vision and eye health care.

Addressing issues prior to referral will facilitate the referral process and enable more efficient care for your patient as well as maximize outcomes.

Luis Rojas, OD, shares his tips and tricks for getting the best fit for multifocal contact lenses, as well as how to leverage custom fittings as a service as a marketing tool.

The American Academy of Orthokeratology & Myopia Control-hosted conference was held September 5-9.

Catch up on what happened in optometry during the week of September 18-September 22.

AAOMC is focusing on new membership growth, diversity, and how they can continue to move the needle in myopia management.

Penned by David Goss, OD, PhD, the book was published by Pacific University Press.

Set your young patients—and their caregivers—up for success in treatment.

Research from Orbis International analyzes the overall wellbeing of children with common childhood vision problems.

According to the company, GATHER-2 24-month results met the primary objective of reducing the rate of GA growth in patients treated with IZERVAY compared to sham.

Oluwatosin U. Smith, MD, shares why she is excited for the conference and why it is relevant for today’s ophthalmologists and optometrists.

The week of September 18-24 will be dedicated to educating the public on IEDs such as uveitis, keratitis, conjunctivitis and more.

The complement C5 inhibitor significantly reduced GA progression.

Catch up on what happened in optometry during the week of September 11-September 15.

Documenting the visual effects and simplifying visual life.

Prevention should be at the forefront of the discussion.

Walgreens Boots Allianc Inc. and CVS Health are among the companies the FDA sent letters to for violating federal law.

According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution) is the first prescription eye drop that targets tear evaporation.

Cochair Peter J. McDonnell, MD, highlights what this year’s conference agenda will mean for clinicians and addresses the anticipated increased patient volume.

What 1 doctor did to increase their capture rate to over 80%.

Catch up on what happened in optometry during the week of September 2-September 8.

The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.

Brooke Messer, OD, FAAO, FSLS, shares her anticipation for the second annual CRU Eye Symposium, emphasizing its focus on pertinent content, actionable practice enhancements, and networking with peers and industry representatives, all in the setting of Napa Valley's wine country.